🔗 Permalink

Inventor profile of:

Nigel H. Greig

City:

Phoenix, Maryland

Country:

United States

Published Applications:

Last publication date:

2026-02-26

Top Assignees for applications by Nigel H. Greig

The entities that hold a legal rights for patent applications filed by inventor Greig Nigel H.:

The USA, as represented by the Secretary, Department of Health and Human Services 4 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 3 Washington, DC United States
University Court of the University of Aberdeen 3 Aberdeen, United Kingdom
P2D INC. 3 Cincinnati, OH United States
The United States of America, as represented by the Secretary, Department of Health & Human Services 2 Rockville, MD United States
Raptor Pharmaceutical Corp. 2 Novato, CA United States
The United States of America as Represented by the Department of Health and Human Services 2 Washington, DC United States
National Institutes of Health (NIH) 2 Bethesda, MD United States
TorreyPines Therapeutics 1 La Jolla, CA United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 1 Bethesda, MD United States
The United States of America, as represented by the Secretary, Dept. of Health and Human Services 1 Bethesda, MD United States
The United States of America as represented by the Department of Health & Human Services 1 Washington, DC United States
The United States, as represented by the Secretary Department of Health and Human Services 1 Rockville, MD United States
PEPTRON INC. 1 Daejeon, South Korea
The United States of America 1 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Serv 1 Bethesda, MD United States
National Institutes of Health (NIH) 1 Bethesda, MA United States
The Gov. of the US, as represented by the Secretary, Dept. of Health & Human Services 1 Bethesda, MD United States
The United States of America, as Represented by the Secretary, Department of Health & Human Services 1 Bethesda, MD United States
AevisBio, Inc. 1 Gaithersburg, MD United States
The United States of America, as represented by the Secretary, Health and Human Services 1 Bethesda, MD United States
The National Institutes of Health and Axonyx, Inc. 1 New York, NY United States
AXONYX, Inc. 1 New York, NY United States

Recent patent applications by Greig Nigel H.

Nigel H. Greig from Phoenix, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-26

US20260055061A1

Chemistry; metallurgy

HALOPHTHALIMIDE COMPOUNDS AND METHODS OF USE AGAINST TBI, INFLAMMATORY DISORDER, AUTOIMMUNE DISORDER, NEURODEGENERATIVE DISEASE OR VIRAL INFECTION

#2 | 2022-08-25

US20220265563A1

Human necessities

Methods of delivering a neuroprotective polypeptide to the central nervous system

#3 | 2021-02-18

US20210047267A1

Chemistry; metallurgy

Thalidomide analogs and methods of use

#4 | 2020-10-15

US20200325102A1

Chemistry; metallurgy

Thalidomide analogs and methods of use

#5 | 2020-02-13

US20200046645A1

Human necessities

Methods of delivering a neuroprotective polypeptide to the central nervous system

#6 | 2018-09-27

US20180273472A1

Chemistry; metallurgy

Thalidomide analogs and methods of use

#7 | 2017-06-29

US20170182022A1

Human necessities

Thio compounds

#8 | 2015-12-17

US20150359784A1

Human necessities

Thio compounds

#9 | 2015-03-12

US20150072930A1

Chemistry; metallurgy

GLP-1, exendin-4, peptide analogs and uses thereof

#10 | 2014-10-16

US20140309436A1

Chemistry; metallurgy

THALIDOMIDE ANALOGS

#11 | 2013-06-06

US20130143922A1

Human necessities

Thio compounds

#12 | 2013-02-07

US20130035363A1

Electricity

Thalidomide analogs

#13 | 2012-12-27

US20120329715A1

Chemistry; metallurgy

GLP-1, exendin-4, peptide analogs and uses thereof

#14 | 2012-11-22

US20120295946A1

Chemistry; metallurgy

Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof

#15 | 2011-10-06

US20110245210A1

Chemistry; metallurgy

Thalidomide analogs

#16 | 2011-01-27

US20110021594A1

Chemistry; metallurgy

Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof

#17 | 2010-06-10

US20100144704A1

Human necessities

Method of reducing amyloid-beta peptide levels using a bisdioxopiperazine

#18 | 2010-04-29

US20100105707A1

Human necessities

METHOD OF TREATING OR PREVENTING OXIDATIVE STRESS-RELATED DISEASE

#19 | 2009-05-21

US20090131501A1

Chemistry; metallurgy

Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof

#20 | 2008-12-25

US20080319032A1

Chemistry; metallurgy

TETRAHYDROBENZOTHIAZOLE ANALOGUES AS NEUROPROTECTIVE AGENTS

#21 | 2006-12-26

US10415765

Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof

#22 | 2006-11-30

US20060270729A1

Chemistry; metallurgy

Agents useful for reducing amylioid precursor protein and treating dementia and methods of use thereof

#23 | 2006-09-21

US20060211728A1

Chemistry; metallurgy

Thalidomide analogs

#24 | 2006-05-18

US20060105940A1

Chemistry; metallurgy

Compound useful in the treatment or prevention of cognitive disorders associated with diabetes and associated methods

InventorID:

80065 ⎘